Low-Frequency-Only Stimulation ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 6 | Parkinson disease | 1 |
6. Parkinson disease
Clinical trials : 2,298 / Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05022147 (ClinicalTrials.gov) | October 4, 2021 | 9/8/2021 | Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease | ENGAGE-PD: Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease | Parkinson Disease;Gait Disorders, Neurologic;Disease Progression;Subthalamic Nucleus;Accidental Fall;Deep Brain Stimulation | Device: High-Frequency-Only Stimulation;Device: Low-Frequency-Only Stimulation;Device: Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation;Device: Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation;Device: Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation;Device: Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation;Drug: OFF Dopaminergic Medication;Drug: ON Dopaminergic Medication | The Cleveland Clinic | NULL | Recruiting | 21 Years | N/A | All | 12 | Phase 1 | United States |